Gene · 10468
Papers3,272
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,272
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Changes in serum myostatin levels among patients with type C liver cirrhosis treated with direct-acting antivirals. | Hepatol Res | 2025 | 40317867 | PubTator, text mining | PubMed |
| AAV-Sparcl1 promotes hair cell regeneration by increasing supporting cell plasticity. | Mol Ther | 2025 | 40181541 | PubTator, text mining | PubMed |
| Activin A Antagonism with Follistatin Reduces Kidney Fibrosis, Injury, and Cellular Senescence-Associated Inflammation in Murine Diabetic Kidney Disease. | Kidney360 | 2025 | 40152935 | PubTator, text mining | PubMed |
| Expression and distribution of activin-follistatin-inhibin axis in the urinary bladder. | Front Mol Biosci | 2025 | 40144023 | PubTator, text mining | PubMed |
| Activin a regulates vascular formation and stabilization in direct coculture of dental pulp stem cells and endothelial cells. | Int Endod J | 2025 | 40106315 | PubTator, text mining | PubMed |
| Bioactive scaffolds for tissue engineering: A review of decellularized extracellular matrix applications and innovations. | Exploration (Beijing) | 2025 | 40040827 | PubTator, text mining | PubMed |
| Follistatin, A Novel Therapeutic Target for Chronic Pain. | Neurosci Bull | 2025 | 40025261 | PubTator, text mining | PubMed |
| Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia. | Sci Rep | 2025 | 40011687 | PubTator, text mining | PubMed |
| Evaluation of Metabolism-Associated Proteins in Abdominal Aortic Aneurysm. | J Vasc Res | 2025 | 39907992 | PubTator, text mining | PubMed |
| The Effect of Exercise on Spexin and Follistatin in Elderly Individuals. | J Cachexia Sarcopenia Muscle | 2025 | 39895162 | PubTator, text mining | PubMed |
| Stem cells (neoblasts) and positional information jointly dominate regeneration in planarians. | Heliyon | 2025 | 39877626 | PubTator, text mining | PubMed |
| Heart to Heal: Unveiling Follistatin's Potential for Myocardial Regeneration. | Circ Res | 2025 | 39819021 | PubTator, text mining | PubMed |
| Effects of Resistance Training on Muscular Adaptations and Inflammatory Markers in Overweight and Obese Men. | Med Sci Sports Exerc | 2025 | 39809255 | PubTator, text mining | PubMed |
| Follistatin From hiPSC-Cardiomyocytes Promotes Myocyte Proliferation in Pigs With Postinfarction LV Remodeling. | Circ Res | 2025 | 39692006 | PubTator, text mining | PubMed |
| The activin-follistatin system: Key regulator of kidney development, regeneration, inflammation, and fibrosis. | Cytokine Growth Factor Rev | 2025 | 39581798 | PubTator, text mining | PubMed |
| Effectiveness of resistance training on body composition, muscle strength, and biomarker in sarcopenic older adults: A meta-analysis of randomized controlled trials. | Arch Gerontol Geriatr | 2025 | 39191151 | PubTator, text mining | PubMed |
| Vascular biomarkers reveal a unique toxicity profile of posttransplant cyclophosphamide: secondary analysis of BMT CTN 0402 and 1202. | Blood Vessel Thromb Hemost | 2024 | 40503168 | PubTator, text mining | PubMed |
| Effects of Explosive vs. Strength Resistance Training on Plantar Flexor Neuromuscular and Functional Capacities in Institutionalized Older Adults: A Randomized Controlled Trial. | J Funct Morphol Kinesiol | 2024 | 39728245 | PubTator, text mining | PubMed |
| Gene Therapy Approach for Treatment of Obese Agouti Mice. | Int J Mol Sci | 2024 | 39596212 | PubTator, text mining | PubMed |
| Common Genetic Factors May Play a Role in the Relationships Between Body Composition, Adipokines, and Low-Back-Pain-Related Disability. | Biomolecules | 2024 | 39595602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10468/papers?page=6